Log In
BCIQ
Print this Print this
 

NDC-1022

  Manage Alerts
Collapse Summary General Information
Company Endece LLC
DescriptionSmall molecule modulator of estrogen receptor 2 (ESR2)
Molecular Target Estrogen receptor 2 (ESR2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today